HomeCompareWENAW vs QYLD

WENAW vs QYLD: Dividend Comparison 2026

WENAW yields 5063.29% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WENAW wins by $70304199583247.85M in total portfolio value
10 years
WENAW
WENAW
● Live price
5063.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70304199583247.88M
Annual income
$67,674,944,133,659,165,000.00
Full WENAW calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — WENAW vs QYLD

📍 WENAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWENAWQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WENAW + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WENAW pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENAW
Annual income on $10K today (after 15% tax)
$430,379.75/yr
After 10yr DRIP, annual income (after tax)
$57,523,702,513,610,285,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, WENAW beats the other by $57,523,702,513,610,280,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENAW + QYLD for your $10,000?

WENAW: 50%QYLD: 50%
100% QYLD50/50100% WENAW
Portfolio after 10yr
$35152099791623.95M
Annual income
$33,837,472,066,829,586,000.00/yr
Blended yield
96.26%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENAW buys
0
QYLD buys
0
No recent congressional trades found for WENAW or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWENAWQYLD
Forward yield5063.29%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$70304199583247.88M$25.4K
Annual income after 10y$67,674,944,133,659,165,000.00$5,659.31
Total dividends collected$70126381934526.08M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: WENAW vs QYLD ($10,000, DRIP)

YearWENAW PortfolioWENAW Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$517,029$506,329.11$10,352$1,192.36+$506.7KWENAW
2$25,019,286$24,466,064.78$10,830$1,347.57+$25.01MWENAW
3$1,133,242,195$1,106,471,558.74$11,460$1,539.07+$1133.23MWENAW
4$48,051,212,061$46,838,642,912.48$12,275$1,777.84+$48051.20MWENAW
5$1,907,518,068,513$1,856,103,271,607.74$13,323$2,078.95+$1907518.06MWENAW
6$70,903,526,356,852$68,862,482,023,543.80$14,667$2,463.34+$70903526.34MWENAW
7$2,468,069,984,799,694$2,392,203,211,597,861.50$16,396$2,960.57+$2468069984.78MWENAW
8$80,463,110,629,918,740$77,822,275,746,183,060.00$18,631$3,612.97+$80463110629.90MWENAW
9$2,457,248,083,727,765,000$2,371,152,555,353,752,000.00$21,548$4,482.15+$2457248083727.74MWENAW
10$70,304,199,583,247,880,000$67,674,944,133,659,165,000.00$25,398$5,659.31+$70304199583247.85MWENAW

WENAW vs QYLD: Complete Analysis 2026

WENAWStock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENAW Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this WENAW vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENAW vs SCHDWENAW vs JEPIWENAW vs OWENAW vs KOWENAW vs MAINWENAW vs XYLDWENAW vs JEPQWENAW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.